Effectiveness of Raltegravir-Based Antiretroviral Therapy in HIV-HCV Coinfected Liver Transplant Recipients: Retrospective Analysis in a Prospective National Cohort Study (RAL-LT-HIV)
Latest Information Update: 05 Nov 2021
At a glance
- Drugs Raltegravir (Primary) ; Abacavir; Emtricitabine; Lamivudine; Non-nucleoside reverse transcriptase inhibitors; Peptide hydrolase inhibitors; Tenofovir
- Indications HIV infections
- Focus Adverse reactions
- Acronyms RAL-LT-HIV
- 15 Feb 2020 Status changed from active, no longer recruiting to completed.
- 20 Dec 2016 New trial record